Dow Down1.60% Nasdaq Down0.39%

Pacira Pharmaceuticals, Inc. (PCRX)

-NasdaqGS
56.28 Down 1.64(2.83%) 4:00PM EST
|After Hours : 56.28 0.00 (0.00%) 4:35PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
Total Revenue 62,213   59,147   58,316   61,792  
Cost of Revenue15,900  18,929  17,580  18,968  
Gross Profit 46,313   40,218   40,736   42,824  
Operating Expenses
Research Development5,893  3,649  5,967  3,887  
Selling General and Administrative35,310  34,752  31,428  31,019  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 5,110   1,817   3,341   7,918  
Income from Continuing Operations
Total Other Income/Expenses Net164  169  (33)113  
Earnings Before Interest And Taxes5,274  1,986  3,308  8,031  
Interest Expense1,907  1,939  1,996  2,056  
Income Before Tax3,367  47  1,312  5,975  
Income Tax Expense281  39  52  173  
Minority Interest -   -   -   -  
Net Income From Continuing Ops3,086  (43)1,260  5,802  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 3,086   8   1,260   5,802  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 3,086   8   1,260   5,802  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.